annual ROE:
-75.69%-34.71%(-84.70%)Summary
- As of today (September 16, 2025), SNDX annual return on equity is -75.69%, with the most recent change of -34.71% (-84.70%) on December 31, 2024.
- During the last 3 years, SNDX annual ROE has fallen by -83.24% (-1102.52%).
- SNDX annual ROE is now -210.19% below its all-time high of 68.69%, reached on December 1, 2011.
Performance
SNDX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly ROE:
-114.61%-22.40%(-24.29%)Summary
- As of today (September 16, 2025), SNDX quarterly return on equity is -114.61%, with the most recent change of -22.40% (-24.29%) on June 30, 2025.
- Over the past year, SNDX quarterly ROE has dropped by -55.65% (-94.39%).
- SNDX quarterly ROE is now -1297.60% below its all-time high of 9.57%, reached on December 31, 2021.
Performance
SNDX quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
SNDX ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -84.7% | -94.4% |
| 3 y3 years | -1102.5% | -10000.0% |
| 5 y5 years | +42.9% | -20.8% |
SNDX ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -1102.5% | at low | <-9999.0% | at low |
| 5 y | 5-year | -1102.5% | +42.9% | -1297.6% | at low |
| alltime | all time | -210.2% | +88.3% | -1297.6% | +63.6% |
SNDX ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | -114.61%(+24.3%) |
| Mar 2025 | - | -92.21%(+23.5%) |
| Dec 2024 | -75.69%(+84.7%) | -74.65%(+10.9%) |
| Sep 2024 | - | -67.33%(+14.2%) |
| Jun 2024 | - | -58.96%(+9.8%) |
| Mar 2024 | - | -53.69%(+13.7%) |
| Dec 2023 | -40.98%(+20.2%) | -47.23%(+7.3%) |
| Sep 2023 | - | -44.01%(+10.0%) |
| Jun 2023 | - | -40.02%(+3.3%) |
| Mar 2023 | - | -38.76%(+1.3%) |
| Dec 2022 | -34.10%(-551.7%) | -38.28%(+822.4%) |
| Sep 2022 | - | -4.15%(-1696.2%) |
| Jun 2022 | - | 0.26%(-95.2%) |
| Mar 2022 | - | 5.43%(-43.3%) |
| Dec 2021 | 7.55%(-113.9%) | 9.57%(-121.4%) |
| Sep 2021 | - | -44.69%(-4.8%) |
| Jun 2021 | - | -46.94%(-10.8%) |
| Mar 2021 | - | -52.64%(-15.7%) |
| Dec 2020 | -54.31%(-59.0%) | -62.46%(-27.7%) |
| Sep 2020 | - | -86.41%(-9.0%) |
| Jun 2020 | - | -94.91%(-21.1%) |
| Mar 2020 | - | -120.30%(+8.4%) |
| Dec 2019 | -132.43% | -110.94%(+4.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | -106.71%(+1.7%) |
| Jun 2019 | - | -104.94%(+4.6%) |
| Mar 2019 | - | -100.31%(+2.8%) |
| Dec 2018 | -94.00%(+45.7%) | -97.59%(+11.1%) |
| Sep 2018 | - | -87.82%(+14.1%) |
| Jun 2018 | - | -76.95%(+7.6%) |
| Mar 2018 | - | -71.53%(+9.9%) |
| Dec 2017 | -64.53%(+9.4%) | -65.08%(+13.2%) |
| Sep 2017 | - | -57.50%(+2.3%) |
| Jun 2017 | - | -56.20%(+12.3%) |
| Mar 2017 | - | -50.05%(+12.0%) |
| Dec 2016 | -58.97%(-25.4%) | -44.69%(+5.1%) |
| Sep 2016 | - | -42.54%(-5.5%) |
| Jun 2016 | - | -45.02%(-25.9%) |
| Mar 2016 | - | -60.78%(-80.7%) |
| Dec 2015 | -79.10%(-87.8%) | - |
| Dec 2014 | -646.60%(+26.7%) | - |
| Sep 2014 | - | -314.98%(+144.7%) |
| Jun 2014 | - | -128.74%(+4.8%) |
| Mar 2014 | - | -122.89%(+133.8%) |
| Dec 2013 | -510.20%(-1599.7%) | -52.57%(+322.9%) |
| Sep 2013 | - | -12.43% |
| Dec 2012 | 34.02%(-50.5%) | - |
| Dec 2011 | 68.69% | - |
FAQ
- What is Syndax Pharmaceuticals, Inc. annual return on equity?
- What is the all time high annual ROE for Syndax Pharmaceuticals, Inc.?
- What is Syndax Pharmaceuticals, Inc. annual ROE year-on-year change?
- What is Syndax Pharmaceuticals, Inc. quarterly return on equity?
- What is the all time high quarterly ROE for Syndax Pharmaceuticals, Inc.?
- What is Syndax Pharmaceuticals, Inc. quarterly ROE year-on-year change?
What is Syndax Pharmaceuticals, Inc. annual return on equity?
The current annual ROE of SNDX is -75.69%
What is the all time high annual ROE for Syndax Pharmaceuticals, Inc.?
Syndax Pharmaceuticals, Inc. all-time high annual return on equity is 68.69%
What is Syndax Pharmaceuticals, Inc. annual ROE year-on-year change?
Over the past year, SNDX annual return on equity has changed by -34.71% (-84.70%)
What is Syndax Pharmaceuticals, Inc. quarterly return on equity?
The current quarterly ROE of SNDX is -114.61%
What is the all time high quarterly ROE for Syndax Pharmaceuticals, Inc.?
Syndax Pharmaceuticals, Inc. all-time high quarterly return on equity is 9.57%
What is Syndax Pharmaceuticals, Inc. quarterly ROE year-on-year change?
Over the past year, SNDX quarterly return on equity has changed by -55.65% (-94.39%)